Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors

Genetic Vaccines and Therapy

Volumn 9, Issue , 2011, Pages

  Grandchamp, Nicolas ^a,b   Henriot, Dorothée ^a,b   Philippe, Stéphanie ^a,c   Amar, Lahouari ^a,d   Ursulet, Suzanna ^a,b   Serguera, Che ^a,e   Mallet, Jacques ^a   Sarkis, Chamsy ^a,b  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b NewVectys   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d LUND UNIVERSITY   (Sweden)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; LENTIVIRUS VECTOR; LYSOZYME;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CHICKEN; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INSULATOR ELEMENT; LENTIVIRINAE; MATRIX ATTACHMENT REGION; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

HUMAN IMMUNODEFICIENCY VIRUS 1; MARMOTA MONAX;

EID: 78650786485     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-9-1     Document Type: Article

References (43)

1. Bayer M, Kantor B, Cockrell A, Ma H, Zeithaml B, Li X, McCown T, Kafri T. A large u3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol Ther 2008, 16:1968-1976. 10.1038/mt.2008.199, 2587457, 18797449.
2. Deglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 2000, 11:179-190. 10.1089/10430340050016256, 10646649.
3. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol 1998, 72:8150-8157. 110156, 9733856.
4. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998, 72:9873-9880. 110499, 9811723.
5. Hawley RG, Covarrubias L, Hawley T, Mintz B. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc Natl Acad Sci USA 1987, 84:2406-2410. 10.1073/pnas.84.8.2406, 304660, 3031683.
6. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000, 25:217-222. 10.1038/76095, 10835641.
7. Sirven A, Ravet E, Charneau P, Zennou V, Coulombel L, Guetard D, Pflumio F, Dubart-Kupperschmitt A. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001, 3:438-448. 10.1006/mthe.2001.0282, 11319904.
8. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-185. 10.1016/S0092-8674(00)80828-4, 10786833.
9. Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J, Charneau P. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 2001, 19:446-450. 10.1038/88115, 11329014.
10. Baekelandt V, Claeys A, Eggermont K, Lauwers E, De Strooper B, Nuttin B, Debyser Z. Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum Gene Ther 2002, 13:841-853. 10.1089/10430340252899019, 11975850.
11. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999, 73:2886-2892. 104046, 10074136.
12. Brun S, Faucon-Biguet N, Mallet J. Optimization of transgene expression at the posttranscriptional level in neural cells: implications for gene therapy. Mol Ther 2003, 7:782-789. 10.1016/S1525-0016(03)00097-2, 12788652.
13. Gaszner M, Felsenfeld G. Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 2006, 7:703-713. 10.1038/nrg1925, 16909129.
14. Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 2001, 4:164-173. 10.1006/mthe.2001.0450, 11545606.
15. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 2003, 21:111-117. 10.1634/stemcells.21-1-111, 12529558.
16. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 2003, 101:4717-4724. 10.1182/blood-2002-09-2991, 12586614.
17. Arumugam PI, Scholes J, Perelman N, Xia P, Yee JK, Malik P. Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol Ther 2007, 15:1863-1871. 10.1038/sj.mt.6300259, 17622240.
18. Robert-Richard E, Richard E, Malik P, Ged C, de Verneuil H, Moreau-Gaudry F. Murine retroviral but not human cellular promoters induce in vivo erythroid-specific deregulation that can be partially prevented by insulators. Mol Ther 2007, 15:173-182. 10.1038/sj.mt.6300030, 17164789.
19. Jakobsson J, Rosenqvist N, Thompson L, Barraud P, Lundberg C. Dynamics of transgene expression in a neural stem cell line transduced with lentiviral vectors incorporating the cHS4 insulator. Exp Cell Res 2004, 298:611-623. 10.1016/j.yexcr.2004.04.037, 15265707.
20. Pikaart MJ, Recillas-Targa F, Felsenfeld G. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 1998, 12:2852-2862. 10.1101/gad.12.18.2852, 317165, 9744862.
21. Hanawa H, Yamamoto M, Zhao H, Shimada T, Persons DA. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element. Mol Ther 2009, 17:667-674. 10.1038/mt.2009.1, 2835111, 19223867.
22. Nielsen TT, Jakobsson J, Rosenqvist N, Lundberg C. Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants. BMC Biotechnol 2009, 9:13. 10.1186/1472-6750-9-13, 2651870, 19239708.
23. Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, Xia P, Malik P. Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther 2009, 17:1527-1536. 10.1038/mt.2009.89, 2835256, 19384292.
24. Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem 2000, 275:32338-32346. 10.1074/jbc.M004148200, 10931834.
25. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008, 452:187-193. 10.1038/nature06781, 18337816.
26. Arumugam PI, Higashimoto T, Urbinati F, Modlich U, Nestheide S, Xia P, Fox C, Corsinotti A, Baum C, Malik P. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther 2009, 17:1929-1937. 10.1038/mt.2009.183, 2835044, 19707188.
27. Desprat R, Bouhassira EE. Gene specificity of suppression of transgene-mediated insertional transcriptional activation by the chicken HS4 insulator. PLoS One 2009, 4:e5956. 10.1371/journal.pone.0005956, 2694267, 19536296.
28. Li CL, Xiong D, Stamatoyannopoulos G, Emery DW. Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol Ther 2009, 17:716-724. 10.1038/mt.2009.7, 2835102, 19240697.
29. Hargrove PW, Kepes S, Hanawa H, Obenauer JC, Pei D, Cheng C, Gray JT, Neale G, Persons DA. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. Mol Ther 2008, 16:525-533. 10.1038/sj.mt.6300394, 18195719.
30. Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 2006, 103:17684-17689. 10.1073/pnas.0606197103, 1693807, 17095605.
31. Rahim AA, Wong AM, Howe SJ, Buckley SM, Acosta-Saltos AD, Elston KE, Ward NJ, Philpott NJ, Cooper JD, Anderson PN, Waddington SN, Thrasher AJ, Raivich G. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther 2009, 16:509-520. 10.1038/gt.2008.186, 19158847.
32. Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, Buch P, MacLaren RE, Anderson PN, Barker SE, Duran Y, Bartholomae C, von Kalle C, Heckenlively JR, Kinnon C, Ali RR, Thrasher AJ. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 2006, 12:348-353. 10.1038/nm1365, 16491086.
33. Philpott NJ, Thrasher AJ. Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther 2007, 18:483-489. 10.1089/hum.2007.013, 17523890.
34. Sarkis C, Philippe S, Mallet J, Serguera C. Non-integrating lentiviral vectors. Curr Gene Ther 2008, 8:430-437. 10.2174/156652308786848012, 19075626.
35. Wanisch K, Yanez-Munoz RJ. Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther 2009, 17:1316-1332. 10.1038/mt.2009.122, 2835240, 19491821.
36. Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, Thrasher AJ, Collins MK, Philpott NJ. Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 2007, 15:1947-1954. 10.1038/sj.mt.6300281, 17700544.
37. Cornu TI, Cathomen T. Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther 2007, 15:2107-2113. 10.1038/sj.mt.6300345, 17998901.
38. Girod PA, Zahn-Zabal M, Mermod N. Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 2005, 91:1-11. 10.1002/bit.20563, 15889435.
39. Buchet D, Serguera C, Zennou V, Charneau P, Mallet J. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Mol Cell Neurosci 2002, 19:389-401. 10.1006/mcne.2001.1086, 11906211.
40. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001, 12:1893-1905. 10.1089/104303401753153947, 11589831.
41. Shin NH, Hartigan-O'Connor D, Pfeiffer JK, Telesnitsky A. Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stages. J Virol 2000, 74:2694-2702. 10.1128/JVI.74.6.2694-2702.2000, 111759, 10684285.
42. Gotte M, Rausch JW, Marchand B, Sarafianos S, Le Grice SF. Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim Biophys Acta 2010, 1804:1202-1212.
43. Rinke CS, Boyer PL, Sullivan MD, Hughes SH, Linial ML. Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity. J Virol 2002, 76:7560-7570. 10.1128/JVI.76.15.7560-7570.2002, 136390, 12097569.